Skip to content

The efficacy and safety of acupuncture in cancer-related fatigue

Efficacy and safety of acupuncture for cancer-related fatigue in patients with breast cancer: a randomized, single-blinded, controlled trial

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
ISRCTN
Registry ID
ISRCTN71727232
Enrollment
40
Registered
2014-04-24
Start date
2014-04-10
Completion date
Unknown
Last updated
2020-08-03

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Cancer-related fatigue Cancer

Interventions

The 40 eligible participants are randomly allocated to two different groups: 1. Participants in the intervention group will receive acupuncture therapy three times a week for 4 weeks

Sponsors

Beijing Administration of Traditional Chinese Medicine (China)
Lead Sponsor

Eligibility

Sex/Gender
Female

Inclusion criteria

Inclusion criteria: 1. Women patients with a definite pathologic diagnosis of breast cancer who had complete chemotherapy and/or radiotherapy at least 1 month before and mastectomy within 5 years 2. Stage I-III breast cancer with no evidence of recurrence and metastasis 3. Eastern Cooperative Oncology Group (ECOG) performance status 0-2 4. Anticipated survival time is more than 6 months 5. Aged 18-65 6. Patients who are suffering from at least moderate fatigue by Revised Piper Fatigue Scale-Chinese Version (RPFS-CV) 7. All patients provided written informed consent before enrollment

Exclusion criteria

Exclusion criteria: 1. Complicated with other primary tumors and serious heart, liver, kidney and hematopoietic system diseases 2. Pregnant women or women who are breastfeeding 3. Patients who had needle phobia 4. Patients who had low platelet count or suffered from a bleeding disorder (e.g., haemophilia) 5. Patients who had lymphoedema at the area of the acupuncture points 6. Patients who were on active treatment for anaemia (i.e., EPO or blood transfusions) 7. Patients who were receiving steroids to combat fatigue 8. Patients who had been diagnosed with depression, anxiety disorders, mental illness and cognitive disorders

Design outcomes

Primary

MeasureTime frame
Revised Piper Fatigue Scale-Chinese Version (RPFS-CV), a multidimensional assessment tool for measuring the level of fatigue subjectively for patients with cancer. It will be assessed before the treatment, at 2 and 4 weeks during the treatment, and 4 weeks after the treatment.

Secondary

MeasureTime frame
1. Eastern Cooperative Oncology Group Performance Status (ECOG PS) . 2. Pittsburgh Sleep Quality Index (PSQI) 3. Simplified Nutritional Appetite Questionnaire (SNAQ) 4. The Hospital Anxiety and Depression Scale (HADS) 5. TCM symptoms scale The outcome measures above will be assessed before the treatment, at 2 and 4 weeks during the treatment, and 4 weeks after the treatment.

Countries

China

Outcome results

None listed

Source: ISRCTN (via WHO ICTRP) · Data processed: Feb 4, 2026